5004202025-01-012025-03-315004202025-03-315004202024-03-315004202024-04-012025-03-315004202025-01-012025-03-31in-capmkt:OtherExpenses1Member5004202024-04-012025-03-31in-capmkt:OtherExpenses1Member5004202025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15004202024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss15004202025-01-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15004202024-04-012025-03-31ItemsThatWillBeReclassifiedToProfitAndLoss15004202025-01-012025-03-31RelatedPartyTransactionDomain15004202024-12-31RelatedPartyTransactionDomain15004202025-03-31RelatedPartyTransactionDomain15004202025-01-012025-03-31RelatedPartyTransactionDomain25004202024-12-31RelatedPartyTransactionDomain25004202025-03-31RelatedPartyTransactionDomain25004202025-01-012025-03-31RelatedPartyTransactionDomain35004202024-12-31RelatedPartyTransactionDomain35004202025-03-31RelatedPartyTransactionDomain35004202025-01-012025-03-31RelatedPartyTransactionDomain45004202024-12-31RelatedPartyTransactionDomain45004202025-03-31RelatedPartyTransactionDomain45004202025-01-012025-03-31RelatedPartyTransactionDomain55004202024-12-31RelatedPartyTransactionDomain55004202025-03-31RelatedPartyTransactionDomain55004202025-01-012025-03-31RelatedPartyTransactionDomain65004202024-12-31RelatedPartyTransactionDomain65004202025-03-31RelatedPartyTransactionDomain65004202025-01-012025-03-31RelatedPartyTransactionDomain75004202024-12-31RelatedPartyTransactionDomain75004202025-03-31RelatedPartyTransactionDomain75004202025-01-012025-03-31RelatedPartyTransactionDomain85004202024-12-31RelatedPartyTransactionDomain85004202025-03-31RelatedPartyTransactionDomain85004202025-01-012025-03-31RelatedPartyTransactionDomain95004202024-12-31RelatedPartyTransactionDomain95004202025-03-31RelatedPartyTransactionDomain95004202025-01-012025-03-31RelatedPartyTransactionDomain105004202024-12-31RelatedPartyTransactionDomain105004202025-03-31RelatedPartyTransactionDomain105004202025-01-012025-03-31RelatedPartyTransactionDomain115004202024-12-31RelatedPartyTransactionDomain115004202025-03-31RelatedPartyTransactionDomain115004202025-01-012025-03-31RelatedPartyTransactionDomain125004202024-12-31RelatedPartyTransactionDomain125004202025-03-31RelatedPartyTransactionDomain125004202025-01-012025-03-31RelatedPartyTransactionDomain135004202024-12-31RelatedPartyTransactionDomain135004202025-03-31RelatedPartyTransactionDomain135004202025-01-012025-03-31RelatedPartyTransactionDomain145004202024-12-31RelatedPartyTransactionDomain145004202025-03-31RelatedPartyTransactionDomain145004202025-01-012025-03-31RelatedPartyTransactionDomain155004202024-12-31RelatedPartyTransactionDomain155004202025-03-31RelatedPartyTransactionDomain155004202025-01-012025-03-31RelatedPartyTransactionDomain165004202024-12-31RelatedPartyTransactionDomain165004202025-03-31RelatedPartyTransactionDomain165004202025-01-012025-03-31RelatedPartyTransactionDomain175004202024-12-31RelatedPartyTransactionDomain175004202025-03-31RelatedPartyTransactionDomain175004202025-01-012025-03-31RelatedPartyTransactionDomain185004202024-12-31RelatedPartyTransactionDomain185004202025-03-31RelatedPartyTransactionDomain185004202025-01-012025-03-31RelatedPartyTransactionDomain195004202024-12-31RelatedPartyTransactionDomain195004202025-03-31RelatedPartyTransactionDomain195004202025-01-012025-03-31RelatedPartyTransactionDomain205004202024-12-31RelatedPartyTransactionDomain205004202025-03-31RelatedPartyTransactionDomain205004202025-01-012025-03-31RelatedPartyTransactionDomain215004202024-12-31RelatedPartyTransactionDomain215004202025-03-31RelatedPartyTransactionDomain215004202025-01-012025-03-31RelatedPartyTransactionDomain225004202024-12-31RelatedPartyTransactionDomain225004202025-03-31RelatedPartyTransactionDomain225004202025-01-012025-03-31RelatedPartyTransactionDomain235004202024-12-31RelatedPartyTransactionDomain235004202025-03-31RelatedPartyTransactionDomain235004202025-01-012025-03-31RelatedPartyTransactionDomain245004202024-12-31RelatedPartyTransactionDomain245004202025-03-31RelatedPartyTransactionDomain245004202025-01-012025-03-31RelatedPartyTransactionDomain255004202024-12-31RelatedPartyTransactionDomain255004202025-03-31RelatedPartyTransactionDomain255004202025-01-012025-03-31RelatedPartyTransactionDomain265004202024-12-31RelatedPartyTransactionDomain265004202025-03-31RelatedPartyTransactionDomain265004202025-01-012025-03-31RelatedPartyTransactionDomain275004202024-12-31RelatedPartyTransactionDomain275004202025-03-31RelatedPartyTransactionDomain275004202025-01-012025-03-31RelatedPartyTransactionDomain285004202024-12-31RelatedPartyTransactionDomain285004202025-03-31RelatedPartyTransactionDomain285004202025-01-012025-03-31RelatedPartyTransactionDomain295004202024-12-31RelatedPartyTransactionDomain295004202025-03-31RelatedPartyTransactionDomain295004202025-01-012025-03-31RelatedPartyTransactionDomain305004202024-12-31RelatedPartyTransactionDomain305004202025-03-31RelatedPartyTransactionDomain305004202025-01-012025-03-31RelatedPartyTransactionDomain315004202024-12-31RelatedPartyTransactionDomain315004202025-03-31RelatedPartyTransactionDomain315004202025-01-012025-03-31RelatedPartyTransactionDomain325004202024-12-31RelatedPartyTransactionDomain325004202025-03-31RelatedPartyTransactionDomain325004202025-01-012025-03-31RelatedPartyTransactionDomain335004202024-12-31RelatedPartyTransactionDomain335004202025-03-31RelatedPartyTransactionDomain335004202025-01-012025-03-31RelatedPartyTransactionDomain345004202024-12-31RelatedPartyTransactionDomain345004202025-03-31RelatedPartyTransactionDomain345004202025-01-012025-03-31RelatedPartyTransactionDomain355004202024-12-31RelatedPartyTransactionDomain355004202025-03-31RelatedPartyTransactionDomain355004202025-01-012025-03-31RelatedPartyTransactionDomain365004202024-12-31RelatedPartyTransactionDomain365004202025-03-31RelatedPartyTransactionDomain365004202025-01-012025-03-31RelatedPartyTransactionDomain375004202024-12-31RelatedPartyTransactionDomain375004202025-03-31RelatedPartyTransactionDomain375004202025-01-012025-03-31RelatedPartyTransactionDomain385004202024-12-31RelatedPartyTransactionDomain385004202025-03-31RelatedPartyTransactionDomain385004202025-01-012025-03-31RelatedPartyTransactionDomain395004202024-12-31RelatedPartyTransactionDomain395004202025-03-31RelatedPartyTransactionDomain395004202025-01-012025-03-31RelatedPartyTransactionDomain405004202024-12-31RelatedPartyTransactionDomain405004202025-03-31RelatedPartyTransactionDomain405004202025-01-012025-03-31RelatedPartyTransactionDomain415004202024-12-31RelatedPartyTransactionDomain415004202025-03-31RelatedPartyTransactionDomain415004202025-01-012025-03-31RelatedPartyTransactionDomain425004202024-12-31RelatedPartyTransactionDomain425004202025-03-31RelatedPartyTransactionDomain425004202025-01-012025-03-31RelatedPartyTransactionDomain435004202024-12-31RelatedPartyTransactionDomain435004202025-03-31RelatedPartyTransactionDomain435004202025-01-012025-03-31RelatedPartyTransactionDomain445004202024-12-31RelatedPartyTransactionDomain445004202025-03-31RelatedPartyTransactionDomain445004202025-01-012025-03-31RelatedPartyTransactionDomain455004202024-12-31RelatedPartyTransactionDomain455004202025-03-31RelatedPartyTransactionDomain455004202025-01-012025-03-31RelatedPartyTransactionDomain465004202024-12-31RelatedPartyTransactionDomain465004202025-03-31RelatedPartyTransactionDomain465004202025-01-012025-03-31RelatedPartyTransactionDomain475004202024-12-31RelatedPartyTransactionDomain475004202025-03-31RelatedPartyTransactionDomain475004202025-01-012025-03-31RelatedPartyTransactionDomain485004202024-12-31RelatedPartyTransactionDomain485004202025-03-31RelatedPartyTransactionDomain485004202025-01-012025-03-31RelatedPartyTransactionDomain495004202024-12-31RelatedPartyTransactionDomain495004202025-03-31RelatedPartyTransactionDomain495004202025-01-012025-03-31RelatedPartyTransactionDomain505004202024-12-31RelatedPartyTransactionDomain505004202025-03-31RelatedPartyTransactionDomain505004202025-01-012025-03-31RelatedPartyTransactionDomain515004202024-12-31RelatedPartyTransactionDomain515004202025-03-31RelatedPartyTransactionDomain515004202025-01-012025-03-31RelatedPartyTransactionDomain525004202024-12-31RelatedPartyTransactionDomain525004202025-03-31RelatedPartyTransactionDomain525004202025-01-012025-03-31RelatedPartyTransactionDomain535004202024-12-31RelatedPartyTransactionDomain535004202025-03-31RelatedPartyTransactionDomain535004202025-01-012025-03-31RelatedPartyTransactionDomain545004202024-12-31RelatedPartyTransactionDomain545004202025-03-31RelatedPartyTransactionDomain545004202025-01-012025-03-31RelatedPartyTransactionDomain555004202024-12-31RelatedPartyTransactionDomain555004202025-03-31RelatedPartyTransactionDomain555004202025-01-012025-03-31RelatedPartyTransactionDomain565004202024-12-31RelatedPartyTransactionDomain565004202025-03-31RelatedPartyTransactionDomain565004202025-01-012025-03-31RelatedPartyTransactionDomain575004202024-12-31RelatedPartyTransactionDomain575004202025-03-31RelatedPartyTransactionDomain575004202025-01-012025-03-31RelatedPartyTransactionDomain585004202024-12-31RelatedPartyTransactionDomain585004202025-03-31RelatedPartyTransactionDomain585004202025-01-012025-03-31RelatedPartyTransactionDomain595004202024-12-31RelatedPartyTransactionDomain595004202025-03-31RelatedPartyTransactionDomain595004202025-01-012025-03-31RelatedPartyTransactionDomain605004202024-12-31RelatedPartyTransactionDomain605004202025-03-31RelatedPartyTransactionDomain605004202025-01-012025-03-31RelatedPartyTransactionDomain615004202024-12-31RelatedPartyTransactionDomain615004202025-03-31RelatedPartyTransactionDomain615004202025-01-012025-03-31RelatedPartyTransactionDomain625004202024-12-31RelatedPartyTransactionDomain625004202025-03-31RelatedPartyTransactionDomain625004202025-01-012025-03-31RelatedPartyTransactionDomain635004202024-12-31RelatedPartyTransactionDomain635004202025-03-31RelatedPartyTransactionDomain635004202025-01-012025-03-31RelatedPartyTransactionDomain645004202024-12-31RelatedPartyTransactionDomain645004202025-03-31RelatedPartyTransactionDomain645004202025-01-012025-03-31RelatedPartyTransactionDomain655004202024-12-31RelatedPartyTransactionDomain655004202025-03-31RelatedPartyTransactionDomain655004202025-01-012025-03-31RelatedPartyTransactionDomain665004202024-12-31RelatedPartyTransactionDomain665004202025-03-31RelatedPartyTransactionDomain665004202025-01-012025-03-31RelatedPartyTransactionDomain675004202024-12-31RelatedPartyTransactionDomain675004202025-03-31RelatedPartyTransactionDomain675004202025-01-012025-03-31RelatedPartyTransactionDomain685004202024-12-31RelatedPartyTransactionDomain685004202025-03-31RelatedPartyTransactionDomain685004202025-01-012025-03-31RelatedPartyTransactionDomain695004202024-12-31RelatedPartyTransactionDomain695004202025-03-31RelatedPartyTransactionDomain695004202025-01-012025-03-31AuditorDomain1iso4217:INRxbrli:pureiso4217:INRxbrli:shares500420TORNTPHARMNOTLISTEDINE685A01028TORRENT PHARMACEUTICALS LIMITEDMain BoardEquity2024-04-012025-03-312025-05-202025-05-13INRCroresQuarterlyFourth quarterSingle segmentGeneric Formulation Business2025-05-2014:20:002025-05-2016:30:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2025-05-20https://www.torrentpharma.com/assets/RPT_policy_fa81df8739.pdffalsefalseNot applicable during this quarter <BR> 2025-01-012025-03-31AuditedStandalone243300000001500000002448000000040200000002050000000-280000000416000000047000000019000000005700000000180200000006460000000-24000000062200000001600000000-12000000014800000000474000000000004740000000-5000000046900000001692300000514140014140.00340.05110.15281. Exceptional item for the quarter and year ended March 31, 2025 relates to a demand raised by the National Pharmaceutical Pricing Authority (NPPA) in 2017 concerning alleged overcharging, which was under judicial consideration before the Hon’ble Gujarat High Court. During the year, the Company submitted detailed representations, which were favourably considered by the NPPA. As a result, the Company’s legal exposure was substantially reduced. Following the issuance of a revised demand by the NPPA, the Company opted to settle the litigation and bring the matter to a definitive close. <BR> <BR> 2. The Income Tax Act, 1961, provides an option to the Company for paying tax at reduced rates (lower tax rate) as per the provisions/conditions defined in the Income Tax Act, 1961 (Section 115BAA). With reference to the same, the Company had previously assessed the option of availing the lower tax rate under Section 115BAA, in future years, and accordingly applied a mixed tax rate of 25.17% for deferred tax items expected to reverse after transitioning into new regime and 34.94% for those expected to reverse before the transition. Based on the current-year evaluation of available MAT credits and deductions under Chapter VIA as at March 31, 2025, the Company has now assessed that it will transition to the new tax regime from FY 2025-26. Consequently, deferred tax balances expected to reverse in or after FY 2025-26 have been remeasured at 25.17%, resulting in a net reversal of deferred tax liabilities of Rs. 151 crores for the year ended March 31, 2025.2024-04-012025-03-31AuditedStandalone9682000000032000000097140000000151800000007320000000-900000001636000000021300000007600000000223000000007080000000026340000000-24000000026100000000541000000018100000007220000000018880000000000018880000000-41000000018470000000169230000057423000000055.7955.790055.7955.790.00340.04080.1443Other Expenses5700000000Other Expenses22300000000313200000003650000000032400000004099000000036000000000411000000003000000017000000043100000000106000000084930000000156100000001120000000217100000001050000000500000004000000012500000002522000000002660000000434900000001284200000001690000000742300000007592000000075920000000102100000000008300000001104000000033800000008280000000002270000000015260000000230000000744000000076700000003050000000259800000001020000000207000000073000000002980000000052500000000128420000000213000000050000000-58100000000-6200000000000200000000121000000007600000000100000000000130000000010000000000-190000000200000000045400000003064000000000049000000000257400000000780000000450000000000010000000018000000044600000000000000000000000001000000000-470000000000000000078800000009000000010830000000224000000000-2104000000000010500000001050000000Amount of items that will not be reclassified to profit and loss-140000000-140000000Amount of items that will not be reclassified to profit and loss-330000000-330000000-10000000-80000000Amount of items that will be reclassified to profit and loss140000000140000000Amount of items that will be reclassified to profit and loss-230000000-23000000060000000-70000000-50000000-410000000Torrent Pharmaceuticals Limited******Torrent Pharma Inc.(TPI), USA******Wholly owned subsidiarySale of goods or services-524480000069363000008630000000Torrent Pharmaceuticals Limited******Torrent Do Brazil Ltda. (TDBL), Brazil******Wholly owned subsidiarySale of goods or services-247810000034000000003372200000Torrent Pharmaceuticals Limited******Torrent Pharma Philippines Inc. (TPPI), Philippines******Wholly owned subsidiarySale of goods or services-497300000585600000549600000Torrent Pharmaceuticals Limited******Laboratories Torrent (Malaysia) Sdn. Bhd., (LTM), Malaysia******Wholly owned subsidiarySale of goods or services-288300000363200000288300000Torrent Pharmaceuticals Limited******ZAO Torrent Pharma (ZAO), Russia******Wholly owned subsidiarySale of goods or services-729300000541200000894400000Torrent Pharmaceuticals Limited******Heumann Pharma GmbH & Co Generica KG, Germany******Step down subsidiarySale of goods or services-1593800000673800000980400000Torrent Pharmaceuticals Limited******Heunet Pharma GmbH, Germany******Step down subsidiarySale of goods or services-2087000007540000079600000Torrent Pharmaceuticals Limited******Laboratorios Torrent S.A. de C.V. (LTSA), Mexico******Wholly owned subsidiarySale of goods or services-314600000384400000319400000Torrent Pharmaceuticals Limited******Torrent Pharma (UK) Ltd (TPUK), UK******Wholly owned subsidiarySale of goods or services-410600000456800000621100000Torrent Pharmaceuticals Limited******Torrent Pharma (Thailand) Co.Ltd., Thailand******Wholly owned subsidiarySale of goods or services-223000001180000024500000Torrent Pharmaceuticals Limited******Torrent International Lanka (Pvt) Ltd., Srilanka******Wholly owned subsidiarySale of goods or services-018000000Torrent Pharmaceuticals Limited******Samir Mehta******Key management personnel of entity or parentRemuneration-2912000000291200000Torrent Pharmaceuticals Limited******Aman Mehta******Key management personnel of entity or parentRemuneration32900000-3290000000Torrent Pharmaceuticals Limited******Shaan Mehta******Close Family Member of Key Management PersonnelRemuneration3000000As per the terms of employment300000000Torrent Pharmaceuticals Limited******Torrent Pharmaceuticals Ltd Employees Group Gratuity Scheme******Trust set up by the Company for employee benefit plansAny other transactionContribution to employee benefit plans500000000Toal approval of Rs. 50 crores for contribution to employee benefit plans and advances28500000000Torrent Pharmaceuticals Limited******Torrent Pharmaceuticals Ltd Employees Group Gratuity Scheme******Trust set up by the Company for employee benefit plansAdvance0Toal approval of Rs. 50 crores for contribution to employee benefit plans and advances0500000500000Advance0Repayable on demandUnsecuredGratuity payment to employeesTorrent Pharmaceuticals Limited******Torrent Pharmaceuticals Ltd Employees Superannuation Scheme******Trust set up by the Company for employee benefit plansAny other transactionContribution to employee benefit plans250000000-11590000000Torrent Pharmaceuticals Limited******Torrent Investments Limited******Parent CompanyAny other transactionRent for leasing of land200000-100000100000200000excluding Goods and Services Tax.Torrent Pharmaceuticals Limited******Torrent Pharma GmbH (TPG), Germany******Wholly owned subsidiaryPurchase of goods or services-2000000200000Torrent Pharmaceuticals Limited******Heumann Pharma GmbH & Co Generica KG, Germany******Step down subsidiaryPurchase of goods or services-400000004000000Torrent Pharmaceuticals Limited******Torrent Australasia Pty Ltd. (TAPL), Australia******Wholly owned subsidiaryPurchase of goods or services-42000000300000Torrent Pharmaceuticals Limited******Mac Healthcare Consulting AG******Director is interestedPurchase of goods or services500000General Omnibus approval granted by the Audit Committee for related party transactions which were not foreseen50000000Torrent Pharmaceuticals Limited******Torrent Power Limited******Fellow SubsidiaryPurchase of goods or services310000000Total approval for purchase of electricity at applicable tariffs at various locations wherein Torrent Power Limited is the supplier of electricity including additional security deposits / Bank Guarantee, if any, to be given/ refunded / Interest Income accrued on total security deposits given / Purchase of any capital assets relating to Power consumption;949000002110000016000000Torrent Pharmaceuticals Limited******Torrent Power Limited******Fellow SubsidiaryInterest received0Total approval for purchase of electricity at applicable tariffs at various locations wherein Torrent Power Limited is the supplier of electricity including additional security deposits / Bank Guarantee, if any, to be given/ refunded / Interest Income accrued on total security deposits given / Purchase of any capital assets relating to Power consumption;000Torrent Pharmaceuticals Limited******UNM Foundation******AssociateAny other transactionContribution towards CSR activity460000000-12780000000Torrent Pharmaceuticals Limited******UNM Foundation******AssociateAny other transactionContribution towards Donation80000000-6130000000Torrent Pharmaceuticals Limited******Torrent Australasia Pty Ltd. (TAPL), Australia******Wholly owned subsidiaryAny other transactionExpenses reimbursement-51000000100000Torrent Pharmaceuticals Limited******Torrent Pharma (Thailand) Co.Ltd., Thailand******Wholly owned subsidiaryAny other transactionExpenses reimbursement-450000068000000Torrent Pharmaceuticals Limited******ZAO Torrent Pharma (ZAO), Russia******Wholly owned subsidiaryAny other transactionExpenses reimbursement-27000005690000031800000Torrent Pharmaceuticals Limited******Torrent Pharma Inc.(TPI), USA******Wholly owned subsidiaryAny other transactionGuarantee Commission Income-376000002450000026400000Torrent Pharmaceuticals Limited******Torrent Pharma Philippines Inc. (TPPI), Philippines******Wholly owned subsidiaryAny other transactionGuarantee Commission Income-19000009000001000000Torrent Pharmaceuticals Limited******Torrent Diagnostics Private Limited******Fellow SubsidiaryAny other transactionRecovery of expenses1500000-50000000excluding Goods and Services Tax.Torrent Pharmaceuticals Limited******Torrent Electricals Limited******Fellow SubsidiaryPurchase of fixed assets60000000-1140000047000000excluding Goods and Services Tax.Torrent Pharmaceuticals Limited******Torrent Pharma Inc.(TPI), USA******Wholly owned subsidiaryAny other transactionGuarantees (withdrawal)/ given (net) (including exchange rate variation)-18100000084627000008643700000Torrent Pharmaceuticals Limited******Torrent Pharma Philippines Inc. (TPPI), Philippines******Wholly owned subsidiaryAny other transactionGuarantees (withdrawal)/ given (net) (including exchange rate variation)-7100000335100000342300000Torrent Pharmaceuticals Limited******Torrent Power Limited******Fellow SubsidiaryAny other transactionGuarantees given0Total approval for purchase of electricity at applicable tariffs at various locations wherein Torrent Power Limited is the supplier of electricity including additional security deposits / Bank Guarantee, if any, to be given/ refunded / Interest Income accrued on total security deposits given / Purchase of any capital assets relating to Power consumption;02870000028700000Torrent Pharmaceuticals Limited******Torrent Power Limited******Fellow SubsidiaryAny other transactionSecurity deposits given/ (refunded) (net)0Total approval for purchase of electricity at applicable tariffs at various locations wherein Torrent Power Limited is the supplier of electricity including additional security deposits / Bank Guarantee, if any, to be given/ refunded / Interest Income accrued on total security deposits given / Purchase of any capital assets relating to Power consumption;019000002000000Inter-corporate deposit0.0675-UnsecuredAs per Regulatory RequirementDeposit as per Regulatory requirement. Interest rate % is as determined by Regulatory authority from time to time.Torrent Pharmaceuticals Limited******Torrent Do Brazil Ltda. (TDBL), Brazil******Wholly owned subsidiaryInvestment-0311100000311100000Torrent Pharmaceuticals Limited******ZAO Torrent Pharma (ZAO), Russia******Wholly owned subsidiaryInvestment-0588000000588000000Torrent Pharmaceuticals Limited******ZAO Torrent Pharma (ZAO), Russia******Wholly owned subsidiaryAny other transactionProvision for diminition in value of investment-0230800000230800000Torrent Pharmaceuticals Limited******Torrent Pharma GmbH (TPG), Germany******Wholly owned subsidiaryInvestment-0233700000233700000Torrent Pharmaceuticals Limited******Torrent Pharma Philippines Inc. (TPPI), Philippines******Wholly owned subsidiaryInvestment-04750000047500000Torrent Pharmaceuticals Limited******Torrent Pharma Inc.(TPI), USA******Wholly owned subsidiaryInvestment-04990000049900000Torrent Pharmaceuticals Limited******TPL (Malta) Limited******Wholly owned subsidiaryInvestment-021298000002129800000Torrent Pharmaceuticals Limited******Farmaceutica Torrent Colombia SAS, Colombia******Wholly owned subsidiaryInvestment-09120000091200000Torrent Pharmaceuticals Limited******Laboratorios Torrent S.A. de C.V. (LTSA), Mexico******Wholly owned subsidiaryInvestment-0279900000279900000Torrent Pharmaceuticals Limited******Torrent Australasia Pty Ltd. (TAPL), Australia******Wholly owned subsidiaryInvestment-030000003000000Torrent Pharmaceuticals Limited******Torrent Pharma (UK) Ltd (TPUK), UK******Wholly owned subsidiaryInvestment-01680000016800000Torrent Pharmaceuticals Limited******Torrent Pharma (Thailand) Co.Ltd., Thailand******Wholly owned subsidiaryInvestment-6130000080300000141700000Torrent Pharmaceuticals Limited******Torrent Pharma (Thailand) Co.Ltd., Thailand******Wholly owned subsidiaryAny other transactionShare application money paid for equity investment, allotment pending--61300000613000000Torrent Pharmaceuticals Limited******Laboratories Torrent (Malaysia) Sdn. Bhd., (LTM), Malaysia******Wholly owned subsidiaryInvestment-077000007700000Torrent Pharmaceuticals Limited******Curatio Inc., Philippines******Wholly owned subsidiaryInvestment-6100000152100000158300000Torrent Pharmaceuticals Limited******Curatio Inc., Philippines******Wholly owned subsidiaryAny other transactionProvision for diminition in value of investment-6100000152100000158300000Torrent Pharmaceuticals Limited******Torrent International Lanka (Pvt) Ltd., Srilanka******Wholly owned subsidiaryInvestment-71000008430000091500000Torrent Pharmaceuticals Limited******Torrent International Lanka (Pvt) Ltd., Srilanka******Wholly owned subsidiaryAny other transactionProvision for diminition in value of investment-71000008430000091500000Torrent Pharmaceuticals Limited******UNM Foundation******AssociateInvestment-0500000500000Heumann Pharma GmbH & Co Generica KG, Germany******Torrent Pharma Inc.(TPI), USA******Fellow Subsidiary of Holding companyLoan-033516000003423300000Loan0.04753 years, extendableUnsecuredBusiness PurposeHeumann Pharma GmbH & Co Generica KG, Germany******Torrent Pharma Inc.(TPI), USA******Fellow Subsidiary of Holding companyInterest received-811000004010000040100000Heumann Pharma GmbH & Co Generica KG, Germany******Torrent Pharma (UK) Ltd (TPUK), UK******Fellow Subsidiary of Holding companyLoan-013235000001306700000Loan0.06145 years, extendableSecuredBusiness PurposeHeumann Pharma GmbH & Co Generica KG, Germany******Torrent Pharma (UK) Ltd (TPUK), UK******Fellow Subsidiary of Holding companyInterest received-393000004340000019400000Heunet Pharma GmbH, Germany******Heumann Pharma GmbH & Co Generica KG, Germany******Fellow SubsidiaryLoan--9232000009353000000Loan0.0456Working Capital Requirement (Short term)UnsecuredBusiness PurposeHeunet Pharma GmbH, Germany******Heumann Pharma GmbH & Co Generica KG, Germany******Fellow SubsidiaryInterest received-20600000122000000Heumann Pharma GmbH & Co Generica KG, Germany******Heunet Pharma GmbH, Germany******Fellow SubsidiaryPurchase of goods or services-1430000000Heumann Pharma GmbH & Co Generica KG, Germany******Torrent Pharma GmbH (TPG), Germany******Parent CompanyAny other transactionExpenses reimbursement-1000000000Heumann Pharma GmbH & Co Generica KG, Germany******Torrent Pharma GmbH (TPG), Germany******Parent CompanyAny other transactionReceivable towards Corporate tax balances setoff in Group Tax filing-950000009500000Heumann Pharma GmbH & Co Generica KG, Germany******Heunet Pharma GmbH, Germany******Fellow SubsidiaryAny other transactionRecovery of expenses-4271000000502600000Torrent Pharma GmbH (TPG), Germany******Heumann Pharma GmbH & Co Generica KG, Germany******Wholly owned subsidiaryInvestment-0310400000310400000Torrent Pharma GmbH (TPG), Germany******Heunet Pharma GmbH, Germany******Wholly owned subsidiaryInvestment-017000001700000TPL (Malta) Limited******Torrent Pharma (Malta) Limited******Wholly owned subsidiaryInvestment-02126000000212600000012765700000AuditedtrueBSR & Co. LLPtrue2025-07-31